Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-157424
Filing Date
2017-05-04
Accepted
2017-05-04 08:31:52
Documents
40
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d331257d10q.htm 10-Q 247102
2 EX-3.1 d331257dex31.htm EX-3.1 79893
3 EX-31.1 d331257dex311.htm EX-31.1 9450
4 EX-31.2 d331257dex312.htm EX-31.2 9523
5 EX-32.1 d331257dex321.htm EX-32.1 5144
  Complete submission text file 0001193125-17-157424.txt   2038784

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT meip-20170331.xml EX-101.INS 248776
7 XBRL TAXONOMY EXTENSION SCHEMA meip-20170331.xsd EX-101.SCH 24798
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE meip-20170331_cal.xml EX-101.CAL 32121
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE meip-20170331_def.xml EX-101.DEF 165125
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20170331_lab.xml EX-101.LAB 246155
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20170331_pre.xml EX-101.PRE 189794
Mailing Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-50484 | Film No.: 17812045
SIC: 2834 Pharmaceutical Preparations